Mucolipidosis Type IV Foundation is ranked #6 of 15 disease & disorders organizations in Atlanta, GA, with an America's Best Score of 75 out of 100, based on its 2024 Form 990.
Mucolipidosis Type IV Foundation is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G20). Contributions are tax-deductible.
1668 Adelia Pl Ne, Atlanta, GA 30329-3808
Among the 23 scored disease & disorders organizations in Atlanta, Mucolipidosis Type IV Foundation holds 8.4 months of operating reserves (peer median 9.1 months), runs a typical yearly surplus of 31.7% (peers: surplus of 2.0%), and has grown spending 117.3% a year (peers: grown spending 8.9% a year).
In fiscal year 2024 it reported $3,776,356 in revenue and $3,084,160 in expenses, with contributions making up 99.6% of revenue.
The Mucolipidosis Type IV Foundation operates to raise contributions from individuals and companies in order to fund medical research grants. All medical reserach grants are provided to researchers studying the cause and symptoms of mucolipidosis type IV with the hope of finding a cure for this disease.
Largest programs · fiscal year 2024
Research to cure mucolipidosis type IV - mass general hospital$717,237 spent · 23.4% of program spending
Research to cure mucolipidosis type IV - umass chan medical school$1,948,905 spent · 63.7% of program spending
Research to cure mucolipidosis type IV$393,164 spent · 12.9% of program spending
Where each dollar went · fiscal year 2024
Of every dollar it spent, 99¢ went to programs, 1¢ to management and 0¢ to fundraising.
Programs $3,059,306
Management $24,854
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
99%
Meets
Compared with Atlanta peers
Measure
This organization
Peer median
Operating reserves
8.4 mo
9.1 mo
Typical margin
+31.7%
+2.0%
Spending growth
+117.3% / yr
+8.9% / yr
Debt load
0.2%
2.6%
Peers: the 23 Atlanta disease & disorders organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$3,776,356Fiscal year 2024
Expenses$3,084,160Fiscal year 2024
Total assets$2,166,558Fiscal year 2024
Total liabilities$3,334Fiscal year 2024
Fiscal year ending December2024
Revenue$3,776,356
Expenses$3,084,160
Net income$692,196
Net assets$2,163,224
Notable sources of revenue
Percent of total revenue
Contributions
$3,760,853
99.6%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$15,503
0.4%
Assets / debt
Total assets
$2,166,558
Total liabilities
$3,334
Net assets
$2,163,224
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$1,080,997
Expenses$656,195
Net income$424,802
Net assets$1,471,028
Notable sources of revenue
Percent of total revenue
Contributions
$1,080,997
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$1,477,459
Total liabilities
$6,431
Net assets
$1,471,028
Compensation
Officers and key employees
$197,833
Share of expenses
30.1%
Fiscal year ending December2022
Revenue$860,271
Expenses$653,162
Net income$207,109
Net assets$1,046,226
Notable sources of revenue
Percent of total revenue
Contributions
$860,271
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$1,047,509
Total liabilities
$1,283
Net assets
$1,046,226
Compensation
Officers and key employees
$160,608
Share of expenses
24.6%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?